Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ovarian Neoplasms × Gene Expression × 1 year × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1

Interventions

Paclitaxel 56 Bevacizumab 56 Carboplatin 52 pembrolizumab 40 olaparib 31 Specimen Handling 26 niraparib 23 Gemcitabine 23 Magnetic Resonance Spectroscopy 21 Cyclophosphamide 21 Nivolumab 19 Cisplatin 18 Biopsy 18 Taxes 17 liposomal doxorubicin 16 fludarabine 14 Fulvestrant 13 Topotecan 12 Immunoglobulin G 11 Doxorubicin 11 Disulfides 11 durvalumab 10 Oxaliplatin 10 Ipilimumab 9 mirvetuximab soravtansine 8 aldesleukin 8 Fluorouracil 8 Docetaxel 8 Blood Specimen Collection 8 atezolizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07169396 2025-09-11

GEN_EXP_CO2021

Azienda USL Reggio Emilia - IRCCS

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡